Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013:2013:538765.
doi: 10.1155/2013/538765. Epub 2013 Mar 14.

Amyotrophic Lateral Sclerosis and Metabolomics: Clinical Implication and Therapeutic Approach

Affiliations
Review

Amyotrophic Lateral Sclerosis and Metabolomics: Clinical Implication and Therapeutic Approach

Alok Kumar et al. J Biomark. 2013.

Abstract

Amyotrophic lateral sclerosis (ALS) is one of the most common motor neurodegenerative disorders, primarily affecting upper and lower motor neurons in the brain, brainstem, and spinal cord, resulting in paralysis due to muscle weakness and atrophy. The majority of patients die within 3-5 years of symptom onset as a consequence of respiratory failure. Due to relatively fast progression of the disease, early diagnosis is essential. Metabolomics offer a unique opportunity to understand the spatiotemporal metabolic crosstalks through the assessment of body fluids and tissue. So far, one of the most challenging issues related to ALS is to understand the variation of metabolites in body fluids and CNS with the progression of disease. In this paper we will review the changes in metabolic profile in response to disease progression condition and also see the therapeutic implication of various drugs in ALS patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) Representative serum NMR spectra of control subjects and ALS patients, (b) and (c) show imbalance between oxidative/antioxidant and glutamate/gluatamine cycle. It has been speculated that glutamate excitotoxicty exacerbates the formation of ROS, which may be responsible for the oxidant-antioxidant imbalance, such as increased BHBT and acetone and decreased concentrations of histidine [26].
Figure 2
Figure 2
(a) Schematic diagram of kynurenine pathway. TDO—tryptophan 2,3-dioxygenase, IDO—indoleamine 2,3-dioxygenase, KAT—kynurenine aminotransferase, KZ—kynureninase, HK—kynurenine 3-hydroxylase, HAO—3-hydroxyanthranilate-3,4-dioxygenase, PC—picolinic carboxylase, NC—nonenzymic cyclization. Details are given in the text. (b) Schematic representation of QUIN toxicity in motor neurons. Due to presence of large number of activated glial cells in ALS, there is release of large amount of QUIN into the microenvironment, which can then result in excitotoxicity in motor neurons via NMDA receptors, or it can also be taken up in large quantities by motor neurons. Ultimately, excitotoxicity and the accumulation of QUIN contribute to the demise of motor neurons.

References

    1. Kurtzke J., Kurland L. The epidemiology of neurologic disease. In: Joynt R., editor. Clinical Neurology. Philadelphia, Pa, USA: J. B. Lippincot; 1989. pp. 1–43.
    1. McGuire V., Longstreth W., Koepsell T. D., van Belle G. Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology. 2006;47(2):571–573. - PubMed
    1. Lilienfeld D. E., Chan E., Ehland J., et al. Rising mortality from motoneuron disease in the USA, 1962–84. Lancet. 1989;1:710–713. - PubMed
    1. Rosen D., Siddique T., Patterson D., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59–62. - PubMed
    1. Kabashi E., Valdmanis P. N., Dion P., et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nature Genetics. 2008;40:572–574. - PubMed

LinkOut - more resources